None listed
Conditions
Interventions
Intervention1: 1. Deodorant (4024A)
2. Deodorant (4023A)
3. Deodorant (4023B)
4. Deodorant (4023C)
5. Deodorant (4023D)
6. Deodorant (4023E)
7. Deodorant (4023F)
8. Hair leave-on (21908A)
9. Skin leav
the product is leave on products so are placed directly in the aluminum chambers of the patch and applied on the back of the volunteers at T0 visit
Sponsors
ITC RD CENTRE
Eligibility
Inclusion criteria
Inclusion criteria: Skin is healthy on the studied anatomic unit (free of eczema,wounds, inflammatory scarâ?¦.) Subjects representing varied skin types (ideally equal representation of all 4 skin types â?? Oily, Normal, Dry and combination) Subjects willing to come for regular follow up and ready to follow instructions during the study period
Exclusion criteria
Exclusion criteria: For female : Being pregnant or breastfeeding or having stopped to breastfeed in the past three months, Having refused to give his/her assent by signing the consent form, Taking part in another study liable to interfere with this study Being diabetic,Being asthmatic,Having eczema, oriasis, lichen plan, vitiligo whatever the considered area, Having disorder of the healing (whatever the considered area),Having a rhinitis, allergic conjunctivitis or rhinosinusitis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the dermatological safety of investigational products by primary irritation patch test on healthy human volunteers of varied skin types Timepoint: T0, T1, T2 and T8 | — |
Secondary
| Measure | Time frame |
|---|---|
| NAPTimepoint: NAP | — |
Countries
India
Contacts
Public ContactDr Mary Francis
Outcome results
None listed